This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Manitoba directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
The Journal of antimicrobial chemotherapy · 2025
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
The Journal of antimicrobial chemotherapy · 2025
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
Drugs · 2024
Latest funding
- $134,249
A Zetaview Multiple Parameter Particle Tracking System for Bioparticle and Nanobubble Research
NSERC · 2025 · Principal investigator
- $104,000
Exploring lipid and efflux-mediated mechanisms of cationic biocide resistance in bacteria
NSERC · 2023 · Principal investigator
- $719,100
Understanding the cellular mechanisms that drive clonal T cell expansion of the HIV reservoir
CIHR · 2022 · Co-investigator
11 publications.
Gram-negative pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
Zhanel GG, Baxter MR, Lagacé-Wiens P, Walkty A, Fuller J, Davidson RJ, Blondeau J, Poutanen S, Lavallée C, Mataseje L, Golding G, Schweizer F, Bay D, Denisuik A, Li J, Karlowsky JA, Adam HJ
Gram-positive pathogens from Canadian hospitals: 17 years of results from the CANWARD study (2007-23).
Zhanel GG, Baxter MR, Golden AR, Lagacé-Wiens P, Walkty A, Fuller J, Davidson RJ, Blondeau J, Poutanen S, Lavallée C, McCracken M, Golding G, Schweizer F, Bay D, Karlowsky JA, Adam HJ
Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination
Zhanel GG, Mansour C, Mikolayanko S, Lawrence CK, Zelenitsky S, Ramirez D, Schweizer F, Bay D, Adam H, Lagacé-Wiens P
Sulopenem: An Intravenous and Oral Penem for the Treatment of Urinary Tract Infections Due to Multidrug-Resistant Bacteria
Zhanel GG, Pozdirca M, Golden AR, Lawrence CK, Zelenitsky S, Berry L, Schweizer F, Bay D, Adam H, Zhanel MA
In vitro activity of fosfomycin against bacterial pathogens isolated from urine specimens in Canada from 2007 to 2020: CANWARD surveillance study.
Karlowsky JA, Baxter MR, Walkty AJ, Lagacé-Wiens PRS, Bay D, Adam HJ, Zhanel GG
Activity of cefepime/taniborbactam and comparators against whole genome sequenced ertapenem-non-susceptible Enterobacterales clinical isolates: CANWARD 2007-19.
Golden AR, Baxter MR, Karlowsky JA, Mataseje L, Mulvey MR, Walkty A, Bay D, Schweizer F, Lagace-Wiens PRS, Adam HJ, Zhanel GG
In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019.
Karlowsky JA, Walkty AJ, Baxter MR, Adam HJ, Lagacé-Wiens PRS, Schweizer F, Bay D, Lynch JP, Mulvey MR, Zhanel GG
Lefamulin: A Novel Oral and Intravenous Pleuromutilin for the Treatment of Community-Acquired Bacterial Pneumonia
Zhanel GG, Deng C, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Berry L, Schweizer F, Zhanel MA, Irfan N
Comparison of phenotypic antimicrobial susceptibility testing results and WGS-derived genotypic resistance profiles for a cohort of ESBL-producing Escherichia coli collected from Canadian hospitals: CANWARD 2007-18.
Golden AR, Karlowsky JA, Walkty A, Baxter MR, Denisuik AJ, McCracken M, Mulvey MR, Adam HJ, Bay D, Zhanel GG
Omadacycline: A Novel Oral and Intravenous Aminomethylcycline Antibiotic Agent.
Zhanel GG, Esquivel J, Zelenitsky S, Lawrence CK, Adam HJ, Golden A, Hink R, Berry L, Schweizer F, Zhanel MA, Bay D, Lagacé-Wiens PRS, Walkty AJ, Lynch JP, Karlowsky JA
A Zetaview Multiple Parameter Particle Tracking System for Bioparticle and Nanobubble Research
Principal investigators: Bay, Denice
Keywords: membrane vesicles; lipid particles; virus-like particles; bacterial membranes; particle size determination; zeta potential; particle concentration measurement; biomembranes; fluorescence; green fluorescent protein
Exploring lipid and efflux-mediated mechanisms of cationic biocide resistance in bacteria
Principal investigators: Bay, Denice
Keywords: biocides; disinfectants; lipopolysaccharides; efflux pumps; lipids; in vitro evolution; mass spectrometry; genomics; lipidomics; proteomics
Understanding the cellular mechanisms that drive clonal T cell expansion of the HIV reservoir
Principal investigators: Murooka, Thomas T
Keywords: Antigen Presentation; Cell Migration; Dendritic Cells; Flourescent Proteins; Hiv Latency; Hiv Reservoir; Hiv-1; Humanized Mouse Models; Microscopy; T Cells
The influence of bacterial lipid composition variation on transporter function and folding.
Principal investigators: Bay, Denice
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Frank Schweizer and Denice Bay: 9 shared papers
- Neal Irfan and Frank Schweizer: 3 shared papers
- Neal Irfan and Denice Bay: 3 shared papers
- Frank Schweizer and Susan Poutanen: 2 shared papers
- Susan Poutanen and Denice Bay: 2 shared papers
- Lionel Mandell and Neal Irfan: 1 shared paper
- Lionel Mandell and Frank Schweizer: 1 shared paper
- Lionel Mandell and Denice Bay: 1 shared paper
- Medicine
- Medical Microbiology
- Chemistry
- Department of Laboratory Medicine and Pathobiology
Co-authors at University of Manitoba, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.